Skip to main content

Global Axial Spondyloarthritis Market is Expected to Grow at Significant CAGR 13.44 During the Forecast Period, 2022-2032

 The ankylosing spondylitis and other members of the spondyloarthritis (SpA) family were considered variations of rheumatoid arthritis (RA) up until the early 1960s. As a result, SpA and RA were initially considered to be separate illnesses, but soon after they were found to be inter-connected due to clinical, laboratory, and imaging features. For the last two decades, axial spondyloarthritis (axSpA) has been the subject of major advances in understanding the disease. Additionally, over the years, the distinction between axial and peripheral SpA as well as the connections between non-radiographic and radiographic axSpA has been formalized. In 2009, the term "axial spondyloarthritis" was introduced to describe a diverse disease family that shares clinical and genetic features, such as involvement of the axial skeleton. The following figure shows the evolution of axSpA over the years. The landscape of axial spondyloarthritis is massively growing, with many emerging and legacy companies venturing into the industry with their respective therapeutic portfolio exclusively developed and designed for the treatment of axial spondyloarthritis (axSpA) such as ankylosing spondylitis and non-radiographic axial spondyloarthritis. Additionally, axSpA is associated with several co-morbidities and extra-articular manifestations such as cardiovascular risk, inflammatory bowel disease, and uveitis. Through imaging, genetic, and biomarker studies, researchers are gaining deeper understanding of the biology of axSpA, which will likely resolve many current problems in axSpA diagnosis and classification. Though there is no cure for axSpA, but there are emerging therapies in the global axial spondylopathies market that improves the symptoms, signs, and quality of life in patients with axSpA.

The current study aims to assess the global axial spondyloarthritis market by focusing on the marketed and potential pipeline therapies catering to ankylosing spondylitis and non-radiographic axial spondyloarthritis. The current market for axial spondyloarthritis is majorly dominated by the pharmaceutical companies such as AbbVie Inc., Amgen Inc., Pfizer Inc., Johnson & Johnson Services, Inc., and Novartis International AG.

The global axial spondyloarthritis market is expected to witness high growth, attributing to the growing prevalence of axial spondyloarthritis, favorable regulatory environment, and increase in adoption of biological agents in the field of axial spondyloarthritis. The continued significant investments by the emerging and legacy companies to meet industry demand and the growing adoption of novel therapeutics by the rheumatologists are the major factors propelling the growth of the global axial spondyloarthritis market.

The preceding figure represents the global axial spondyloarthritis market from 2021 to 2032. The market size in 2021 was $1,873.8 million and is expected to reach $7,954.9 million in 2032, growing at a CAGR of 13.44% during the forecast period, 2022-2032.

Comments

Post a Comment

Popular posts from this blog

Farm Management Software and Data Analytics Market Future Prospects And Competitive Analysis 2020-2026

The growth in the global farm management software and data analytics market is expected to be driven by increasing demand for agricultural mechanization and automation along with increasing average farm size in certain countries such as Australia and Canada. Report Preview is available at: https://bisresearch.com/industry-report/global-farm-management-software-data-analytics-market.html Farm management software and data analytic solutions not only offer increased transparency in the agricultural field but also decrease the chances of pest attack and crop failure. Increased agricultural production will help in catering to the growing population and uplifting the global agricultural industry. A major factor driving the farm management software and data analytics market is the increase in government initiatives and support toward agricultural digitization. Government initiatives increase the awareness regarding the farm management software and the benefits these solutions entail when appl...
Post a Comment
Read more

Intelligent Lighting Controls Market Report

The report constitutes an extensive study of intelligent lighting controls market. It includes a thorough analysis of different component types as well as different connection types used in the intelligent lighting controls. Intelligent lighting controls market has further been segmented in terms of application which helps in understanding the behavior of different verticals in using intelligent lighting controls. It further explains the driving forces, challenges and growth opportunities of the intelligent lighting controls market. Major players have been identified on the basis of revenue generation, geographical presence and developments related to intelligent lighting controls. A detailed company profiling has been done in order to understand the player’s strategic behavior. The intelligent lighting controls market is further explained and analyzed on the basis of geography. The geographical analysis has been categorized into four regions namely: North America, Europe, Asia-Pa...
Post a Comment
Read more

Market Intelligence on Global Radiation Dose Management Market

The BIS Research Report Global Radiation Dose Management Market offers a comprehensive perspective on the analysis of the industry. The research is based on extensive primary interviews (in-house experts, industry leaders, and market players) and secondary research (a host of paid, and unpaid databases), along with the analytical tools, that have been used to build the forecast and the predictive models. The report is a compilation of various segmentations including the market breakdown by product types such as DoseM, Radimetrics Enterprise Platform, DoseTrack, DoseWise Portal, NEXO [DOSE], and teamplay Dose. The market is also breakdown by modalities such as computed tomography, X-ray, computed radiography & digital radiography, mammography systems, interventional angiography systems, PET scanners, SPECT, fluoroscopy systems, and hybrid imaging systems. While highlighting the critical driving and restraining forces for this market, the report also provides a detailed study ...
Post a Comment
Read more